SupplySide West 2015

Todd A. Harrison

Tuesday, October 6, 2015, 11:00 a.m. - 12:20 p.m. PT
NCN Ingredients & Technology Investor Meeting VII at SupplySide West
Education Session: Ingredient & Technology Innovation: Firm Foundational Steps to Commercialization

Todd Harrison will speak on a panel, Ingredient & Technology Innovation: Firm Foundational Steps to Commercialization, that will discuss key considerations on clinical research, legal, IP & regulatory landscaping, and commercialization and go-to-market strategies.

Andrew F. Pratt

Justin E. Pierce

Wednesday, October 7, 2015, 12:00 p.m. - 12:50 p.m. PT
VendorBrief Booth #400
Brand Integrity for Food & Ingredient Suppliers: Best Practices in Enforcement & Licensing

Venable's Andrew Pratt and Justin Pierce will host a VendorBrief on Brand Integrity for Food & Ingredient Suppliers: Best Practices in Enforcement & Licensing. Complying with FDA regulations can be a difficult process. Small wonder then that some companies choose to deal in unapproved ingredients or products that contain them. Agency scrutiny of so many companies is unlikely, which, in turn, allows these illicit markets to flourish. The hosts will discuss how the ITC can be a simple, fast and powerful solution, and how to effectively orchestrate court ‎actions and advocacy initiatives to counter unfair competition from unscrupulous ingredient suppliers.

Special In-Booth Reception
Wednesday, October 7, 2015, 3:00 p.m. - 4:30 p.m. PT
Come Join KGK and Venable LLP for cocktails and appetizers at our booth #1845.

Venable's food and drug practice operates at the intersection of the FDA and the FTC, and has decades of marketplace experience assisting clients at all stages of the product life cycle. Come meet the team and let us tell you how we can help your product move from development and regulatory approval/clearance to advertising, marketing and distribution.

We look forward to meeting with you!

In Case You Missed It…

NCN Conference Call: Trends in the Business of Nutrition Science: A clinical and legal perspective on developing and positioning products for health claims.

Venable partnered with NCN's continued series on overcoming business challenges in the nutrition and health & wellness industry with a webinar-type discussion on the science-clinicals-claims continuum, and how companies can best plan and execute cost-effective clinical trials and pattern product claims in a legal context.

This free conference call was led by Najla Guthrie, CEO of KGK Synergize, and Todd Harrison, Co-Chair of the FDA Practice at Venable LLP, who presented brief summaries of their points of view, followed by a discussion facilitated by NCN and involving questions emailed or posted by participants.